48
Participants
Start Date
December 27, 2019
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
TS-1
Intervention is administered to patients in this Arm.
Gemcitabine
Intervention is administered to patients in this Arm.
Nivolumab
Intervention is administered to patients in this Arm.
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Chang Gung Memorial Hospital, Linkou District
China Medical University Hospital, Taichung
National Cheng Kung University Hospital, Tainan City
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Taipei Veterans General Hospital, Taiwan
OTHER_GOV
Chang Gung Memorial Hospital
OTHER
China Medical University Hospital
OTHER
National Cheng-Kung University Hospital
OTHER
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
National Taiwan University Hospital
OTHER
National Health Research Institutes, Taiwan
OTHER